查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942623

2026年全球冠状动脉支架市场报告

Coronary Stents Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，冠状动脉支架市场显着扩张，预计将从2025年的119亿美元成长到2026年的129亿美元，复合年增长率为8.3%。过去几年的增长可归因于冠状动脉疾病盛行率的上升、经皮冠状动脉介入治疗（PCI）手术数量的增加、支架涂层技术的进步、介入性心臟病学服务的扩展以及冠状动脉支架置入术临床疗效的改善。

预计未来几年冠状动脉支架市场将维持强劲成长，到2030年市场规模将达到177.6亿美元，复合年增长率（CAGR）为8.3%。预测期内的成长要素包括：人口老化加剧，心血管风险增加；对微创心臟治疗的需求不断增长；新一代支架技术的应用日益普及；对长期血管癒合和患者预后的关注度不断提高；以及新兴市场心臟护理服务的覆盖范围不断扩大。预测期内的主要趋势包括：药物释放型和双效治疗支架的应用日益广泛；微创冠状动脉介入治疗越来越受欢迎；人们越来越重视降低血管再阻塞和血栓症的风险；生物可吸收和生物降解支架的使用日益增多；以及对先进支架材料和设计的需求不断增长。

心血管疾病（CVD）盛行率的不断上升预计将推动冠状动脉支架市场的扩张。心血管疾病包括多种心臟和血管疾病，如冠状动脉疾病、心臟衰竭、中风和高血压。心血管疾病发生率的上升归因于人口老化以及肥胖、糖尿病、缺乏运动、不健康饮食和压力等风险因素的增加。冠状动脉支架在治疗心血管疾病中至关重要，因为它们可以疏通狭窄或阻塞的冠状动脉，改善心臟血流，并降低心肌梗塞的风险。例如，根据美国疾病管制与预防中心（CDC）的数据，2023年心血管疾病将导致919,032人死亡，约占所有死亡人数的三分之一。心血管疾病的这种上升趋势正在推动对冠状动脉支架的需求。

冠状动脉支架市场的企业正致力于研发先进产品，例如药物释放型支架。与传统的裸金属支架相比，药物洗脱支架能够最大限度地减少再次手术的需求。药物释放型支架是一种特殊的装置，其表面涂有药物，可以缓慢释放药物，从而预防动脉血管再阻塞。例如，2024年5月，总部位于美国的医疗保健公司雅培在印度推出了XIENCE SierraEverolimus洗脱冠状动脉支架系统。这款支架采用了改进的设计、全新的输送系统，并针对复杂病例提供独特的尺寸选择。与其他XIENCE支架一样，它也采用了特殊的涂层，可降低动脉再阻塞的风险，并拥有极高的安全性，这得益于超过120项临床试验（涉及超过12万名患者）的支持。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球冠状动脉支架市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术和循环经济
  • 主要趋势
    • 药物释放型和双重疗法支架的应用日益增多
    • 人们越来越倾向于选择微创冠状动脉介入治疗
    • 更加重视降低血管再阻塞和血栓症的风险
    • 扩大生物可吸收和生物可降解支架的应用
    • 对先进支架材料和设计的需求不断增长

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心
  • 专科心臟诊所
  • 心臟导管检查室
  • 介入性心臟病中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球冠状动脉支架市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球冠状动脉支架市场规模、对比及成长率分析
  • 全球冠状动脉支架市场表现：规模与成长，2020-2025年
  • 全球冠状动脉支架市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依产品类型
  • 双效支架、放射性支架、血栓切除支架、涂层支架、生物可吸收支架、生物降解支架、混合支架、药物释放型支架、裸金属支架
  • 透过技术
  • 雷射切割、3D列印支架、微加工、奈米技术支架、电解及其他技术
  • 按原料
  • 钴铬合金、不锈钢、铂铬合金、镍钛合金、聚合物
  • 透过部署
  • 自动扩张型支架，球囊扩张型支架
  • 透过使用
  • 医院及门诊手术中心、专科诊所及其他终端用途
  • 按类型细分：双重治疗支架
  • Sirolimus洗脱双效支架、紫杉醇洗脱双效支架、Everolimus洗脱双效支架
  • 按类型细分：放射性支架
  • β射线支架、γ射线支架和其他放射性支架
  • 按类型细分：血栓切除支架
  • 手动血栓切除支架、机械血栓切除支架、液压血栓切除支架
  • 按类型细分：覆膜支架
  • 聚四氟乙烯涂层支架、膨体聚四氟乙烯涂层支架、聚氨酯涂层支架及其他涂层支架
  • 按类型细分：生物可吸收支架
  • 聚合物基生物可吸收支架、金属基生物可吸收支架、陶瓷基生物可吸收支架
  • 按类型细分：可生物降解支架
  • 可生物降解聚合物支架、镁基可生物降解支架和其他可生物降解支架
  • 按类型细分：混合支架
  • 混合药物释放型支架、混合可生物降解或金属支架等混合支架
  • 按类型细分：药物释放型支架
  • Sirolimus洗脱支架、紫杉醇洗脱支架、Everolimus洗脱支架、佐他莫司洗脱支架及其他药物释放型支架
  • 按类型细分：裸金属支架
  • 不锈钢裸金属支架、钴铬合金裸金属支架、其他裸金属支架

第十章 区域与国家分析

  • 全球冠状动脉支架市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球冠状动脉支架市场：依国家、市场表现及预测（2020-2025年、2025-2030年预测、2035年预测）

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 冠状动脉支架市场：竞争格局与市场份额，2024 年
  • 冠状动脉支架市场：公司估值矩阵
  • 冠状动脉支架市场：公司简介
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • Terumo Corporation
    • BIOTRONIK SE & Co KG

第37章：其他领先和创新企业

  • B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年冠状动脉支架市场：提供新机会的国家
  • 2030年冠状动脉支架市场：充满新机会的细分市场
  • 2030年冠状动脉支架市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MCSTE02_G26Q1

Coronary stents are small, expandable tubes used to open narrowed or blocked coronary arteries, which supply blood to the heart muscle. Typically constructed from metal mesh, these devices are inserted during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent is delivered via a balloon catheter and expanded at the blockage site to restore proper blood flow.

The main types of coronary stents include dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents integrate drug-eluting and bioresorbable technologies to offer both medication release and gradual absorption of the stent structure. Various technologies used in their manufacture include laser cutting, 3D printing, microfabrication, nanotechnology, and electropolishing. Materials used in stent production can include cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. Stents can be self-expandable or balloon-expandable and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

Tariffs are impacting the coronary stents market by increasing costs for imported raw materials such as cobalt-chromium alloys, polymers, and precision manufacturing components used in advanced stent production. These cost pressures have particularly affected drug-eluting, bioresorbable, and hybrid stent segments, with asia-pacific and europe being more exposed due to global manufacturing dependencies. Increased tariffs have raised procurement costs for hospitals and ambulatory surgical centers. However, tariffs have also encouraged localized manufacturing, material innovation, and regional supply chain diversification, supporting long-term market resilience.

The coronary stents market research report is one of a series of new reports from The Business Research Company that provides coronary stents market statistics, including coronary stents industry global market size, regional shares, competitors with a coronary stents market share, detailed coronary stents market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. This coronary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary stents market size has grown strongly in recent years. It will grow from $11.9 billion in 2025 to $12.9 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, increasing number of percutaneous coronary intervention procedures, advancements in stent coating technologies, expansion of interventional cardiology services, improved clinical outcomes of coronary stenting.

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $17.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to aging population with higher cardiovascular risk, increasing demand for minimally invasive cardiac treatments, growing adoption of next-generation stent technologies, rising focus on long-term vessel healing and patient outcomes, expanding access to cardiac care in emerging markets. Major trends in the forecast period include rising adoption of drug-eluting and dual therapy stents, increasing preference for minimally invasive coronary interventions, growing focus on reducing restenosis and thrombosis risks, expansion of bioresorbable and biodegradable stent usage, increasing demand for advanced stent materials and designs.

The growing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market. CVDs encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population, increased rates of risk factors such as obesity, diabetes, sedentary lifestyles, poor diet, and stress. Coronary stents are crucial in treating CVDs as they help open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, representing approximately one in every three deaths. This rising prevalence of CVDs is driving the demand for coronary stents.

Companies in the coronary stent market are focusing on developing advanced products such as drug-eluting stents to minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents are specialized devices coated with medication that gradually releases drugs to prevent the re-narrowing of arteries. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an enhanced design, a new delivery system, and unique size options tailored for complex cases. It maintains a specialized coating to reduce the risk of artery re-blockage, consistent with other XIENCE stents, and boasts a strong safety record supported by over 120 clinical trials involving more than 120,000 patients.

In November 2023, OrbusNeich Medical Group Holdings Limited, a China-based medical device company, acquired Eucatech AG for an undisclosed amount. Through this acquisition, OrbusNeich seeks to expand its cardiovascular product portfolio, strengthen its position in the global angioplasty and stent markets, accelerate innovation in vascular intervention solutions, and enhance its commercial presence across Europe and other key regions. Eucatech AG is a Germany-based medical device company that provides coronary stents.

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys

North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Stents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses coronary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coronary stents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Dual Therapy Stents; Radioactive Stents; Thrombectomy Stents; Covered Stents; Bioresorbable Stents; Biodegradable Stents; Hybrid Stents; Drug-Eluting Stents; Bare Metal Stents
  • 2) By Technology: Laser Cutting; 3D-Printed Stents; Microfabrication; Nanotechnology-Based Stents; Electropolishing; Others Technologies
  • 3) By Raw Material: Cobalt-Chromium; Stainless Steel; Platinum-Chromium; Nickel-Titanium; Polymer
  • 4) By Deployment: Self-Expandable Stents; Balloon-Expandable Stents
  • 5) By End Uses: Hospitals And Ambulatory Surgical Centers; Specialty Clinics; Other End Uses
  • Subsegments:
  • 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents; Paclitaxel-Eluting Dual Therapy Stents; Everolimus-Eluting Dual Therapy Stents
  • 2) By Radioactive Stents: Beta Radiation Stents; Gamma Radiation Stents; Other Radiation Stents
  • 3) By Thrombectomy Stents: Manual Thrombectomy Stents; Mechanical Thrombectomy Stents; Hydrodynamic Thrombectomy Stents
  • 4) By Covered Stents: PTFE-Covered Stents; ePTFE-Covered Stents; Polyurethane-Covered Stents; Other Covered Stents
  • 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents; Metal-Based Bioresorbable Stents; Ceramic-Based Bioresorbable Stents
  • 6) By Biodegradable Stents: Polymeric Biodegradable Stents; Magnesium-Based Biodegradable Stents; Other Biodegradable Stents
  • 7) By Hybrid Stents: Hybrid Drug-Eluting Stents; Hybrid Biodegradable Or Metal Stents; Other Hybrid Stents
  • 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents; Paclitaxel-Eluting Stents; Everolimus-Eluting Stents; Zotarolimus-Eluting Stents; Other Drug-Eluting Stents
  • 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents; Cobalt Chromium Bare Metal Stents; Other Bare Metal Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; BIOTRONIK SE & Co KG; B Braun Melsungen AG; Biosensors International Group Ltd; MicroPort Scientific Corporation; Lepu Medical Technology Beijing Co Ltd; Meril Life Sciences Pvt Ltd; Stentys SA; Alvimedica; Vascular Concepts; Balton Medical; Cardionovum; HEXACATH; Elixir Medical Corporation; Translumina GmbH; Relisys Medical Devices Ltd; REVA Medical Inc; Sahajanand Medical Technologies Pvt Ltd; Endocor GmbH; Eurocor Tech; Medinol; Q3 Medical Devices; S3V Vascular Technologies; InSitu Technologies; Minvasys
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Coronary Stents Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Coronary Stents Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Coronary Stents Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Coronary Stents Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Drug-Eluting And Dual Therapy Stents
    • 4.2.2 Increasing Preference For Minimally Invasive Coronary Interventions
    • 4.2.3 Growing Focus On Reducing Restenosis And Thrombosis Risks
    • 4.2.4 Expansion Of Bioresorbable And Biodegradable Stent Usage
    • 4.2.5 Increasing Demand For Advanced Stent Materials And Designs

5. Coronary Stents Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Specialty Cardiology Clinics
  • 5.4 Cardiac Catheterization Laboratories
  • 5.5 Interventional Cardiology Centers

6. Coronary Stents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Coronary Stents Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Coronary Stents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Coronary Stents Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Coronary Stents Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Coronary Stents Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Coronary Stents Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Coronary Stents Market Segmentation

  • 9.1. Global Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
  • 9.2. Global Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Other Technologies
  • 9.3. Global Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer
  • 9.4. Global Coronary Stents Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Self-Expandable Stents, Balloon-Expandable Stents
  • 9.5. Global Coronary Stents Market, Segmentation By End Uses, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
  • 9.6. Global Coronary Stents Market, Sub-Segmentation Of Dual Therapy Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
  • 9.7. Global Coronary Stents Market, Sub-Segmentation Of Radioactive Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
  • 9.8. Global Coronary Stents Market, Sub-Segmentation Of Thrombectomy Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
  • 9.9. Global Coronary Stents Market, Sub-Segmentation Of Covered Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
  • 9.10. Global Coronary Stents Market, Sub-Segmentation Of Bioresorbable Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
  • 9.11. Global Coronary Stents Market, Sub-Segmentation Of Biodegradable Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
  • 9.12. Global Coronary Stents Market, Sub-Segmentation Of Hybrid Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
  • 9.13. Global Coronary Stents Market, Sub-Segmentation Of Drug-Eluting Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
  • 9.14. Global Coronary Stents Market, Sub-Segmentation Of Bare Metal Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

10. Coronary Stents Market Regional And Country Analysis

  • 10.1. Global Coronary Stents Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Coronary Stents Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Coronary Stents Market

  • 11.1. Asia-Pacific Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Coronary Stents Market

  • 12.1. China Coronary Stents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Coronary Stents Market

  • 13.1. India Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Coronary Stents Market

  • 14.1. Japan Coronary Stents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Coronary Stents Market

  • 15.1. Australia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Coronary Stents Market

  • 16.1. Indonesia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Coronary Stents Market

  • 17.1. South Korea Coronary Stents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Coronary Stents Market

  • 18.1. Taiwan Coronary Stents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Coronary Stents Market

  • 19.1. South East Asia Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Coronary Stents Market

  • 20.1. Western Europe Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Coronary Stents Market

  • 21.1. UK Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Coronary Stents Market

  • 22.1. Germany Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Coronary Stents Market

  • 23.1. France Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Coronary Stents Market

  • 24.1. Italy Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Coronary Stents Market

  • 25.1. Spain Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Coronary Stents Market

  • 26.1. Eastern Europe Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Coronary Stents Market

  • 27.1. Russia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Coronary Stents Market

  • 28.1. North America Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Coronary Stents Market

  • 29.1. USA Coronary Stents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Coronary Stents Market

  • 30.1. Canada Coronary Stents Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Coronary Stents Market

  • 31.1. South America Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Coronary Stents Market

  • 32.1. Brazil Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Coronary Stents Market

  • 33.1. Middle East Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Coronary Stents Market

  • 34.1. Africa Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Coronary Stents Market Regulatory and Investment Landscape

36. Coronary Stents Market Competitive Landscape And Company Profiles

  • 36.1. Coronary Stents Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Coronary Stents Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Coronary Stents Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. BIOTRONIK SE & Co KG Overview, Products and Services, Strategy and Financial Analysis

37. Coronary Stents Market Other Major And Innovative Companies

  • B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc

38. Global Coronary Stents Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Coronary Stents Market

40. Coronary Stents Market High Potential Countries, Segments and Strategies

  • 40.1 Coronary Stents Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Coronary Stents Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Coronary Stents Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer